臺灣博碩士論文加值系統

乙醯化作用是芳香胺類致癌物主要代謝路線，經由細胞質內N-乙醯轉移酵素(N-acetyltransferase,NAT)利用乙醯輔助酵素A的乙醯基來進行乙醯化。改變肝中乙醯轉移酵素活性與人類癌症如膀胱和乳癌的產生有關。BHT Butylated hydroxyanisol (BHA) 和Butylated hydroxytoluene (BHT)是合成酚類抗氧化劑，已經被報告含有抗癌的特性。例如能抑制由實驗老鼠的肝癌和膀胱癌的產生。但是目前沒有文獻報告有關BHA和BHT抑制大白鼠 (SD) 白血球細胞乙醯轉移酵素活性及人類膀胱癌細胞NAT酵素的活性。因而此研究計劃主要專注於BHA和BHT能否影響人類膀胱癌細胞NAT的活性、細胞週期、DNA 斷裂、細胞形態。本研究發現白血球細胞內 AF (aminofluorene) 的乙醯化，BHA 和 BHT 對大白鼠 (SD) 白血球細胞乙醯轉移酵素活性的抑制作用時間可達24小時。 BHA和BHT能抑制人類膀胱癌細胞(T-24) NAT的活性、明顯地抑制癌細胞的細胞週期(合成期)、也會造成癌細胞中DNA的斷裂。

N-acetylation, a major metabolic pathway for arylamine carcinogen,is catalyzed by cytosolic arylamine N-acetyltransferase(NAT) using acetyl coenzymeA as an acetyl group. Attenuation of NAT activity is associated with several disease processes such as bladder and breast cancer.Butylated Hydroxyanisole (BHA) and Butylated Hydroxytolene(BHT) are synthetic phenolic antioxidants,had been demonstrate to possess cancer preventive properties such as inhibit the liver and bladder cancer development in experimental rats.However,there is no reports to address BHA and BHT affect NAT activity of bladder cancer cells. Thus our proposed study focus on the effect of BHA and BHT on the NAT activity from S-D rat WBC and human bladder cancer cells(T-24).We also examined the Cell Cycle via Flow cytometry,DNA fragmentation,and cell morphology.The result shows The NAT activity of S-D rat WBCand T-24 were supressed by BHA and BHT in a dose-dependent manner.The BHA and BHT also inhibits the S-phase of T-24 cell cycle.We found that BHA and BHT induced T-24 cell DNA fragmentation and Cell morphology destruction.

誌謝 1
中文摘要 2
目錄 3
表目錄 4
圖目錄 5
符號與縮寫 6
前言 7
總論 9
材料 17
方法 19
結果(含圖表) 22
討論 46
參考文獻 52
英文摘要 55
作者簡歷 56
著作權聲明 57

1. Miller .E.C. and Miller J.A. (1981). Search for the ultimate chemical carcinogens and their reaction with cellular macromolectles. Cancer 47, 2327-2345
2. Parker H. G. and Evans A. E. Z. (1984). Epidemiology of aromatic amine cancers. In Searle, C. E. (ed), Chemical Carcinogens 2nd. American Chemical Society, Washington, D. C. ACS Monograph 182. pp.277-302.
3. Weber W. W. (1987). The acetylator genes and drug response. Oxford university Press, New York.
4. Vatsis K.P. and Weber W.W.(1993). Structural heterogeneity of caucasian N-acetyltransferase at the NAT1 gene locus. Archives of Biochemistry and Biophysice. 301, 71-76.
5. Hein D. W., Smolen T. N., Fox R. R. and Weber W. W.(1982a).Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbredrabbit strains. J. Pharmacol. Ext. Ther. 223, .40-44.
6. Hein D. W., Omichinski J. G., Brewer J. A. and Wwber W. W.(1982b).Aunique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster. J. Pharmacol. Exp. Ther. 220, 8-15.
7. Hein D. W., Rustan J. D., Bucher K. D., Furman E. J. and Martin W. J.(1991) Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organ of an inbred rat moder. J. Pharmacol. Exp. Ther. 258, 232-236.
8. Chung J.G., Levy G. N. and Weber W. W.(1993). Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity intissues of C57BL/6J rapid and B6. A-Nats slow acetylator cogenicmice. Drug Metab. Dispos. 21, 1057-1063.
9. Hein D. W., Kirlin W. G., Ferguson R. J., Thompson L. K. and Ogolla F.(1986) Identification of inheritance of inbred hamster N-acetyltransferase isozymes in peripheral blood. J. Pharmacol. Exp. Ther.239, 823-828.
10. Lang N. P., Chu D. Z., Hunter C. F., Kendal D. C., Flammang T. J. and Kadlubar F. F.(1986). Role of aromatic amine acetyltransferase in human colorectal cancer. Arch Surg. 121:1259-1261.
11. Ilett K. F., David B. M., Detchon P., Castledon W. M., and Kwa R.(1987) Acetylator phenotype in colorectal carcinoma. Cancer Res. 47, 1466-1469.
12. Wattenberg, L. W.(1972) Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by phenolic antioxidants and ethoxyquin. J. Natl. Cancer Inst. 48, 1425-1430.
13. Wattenberg, L. W. (1980) Inhibitors of chemical carcinogensis. J. Environ. Pathol. Toxicol. 3, 35-52.
14. Ito, N., Fukushima, S., Hagiwara, A., Shibata, M., and Ogiso, T.(1983) Carcinogenicity of butylated hydroxyanisole in F344 rats. J. Natl. Cancer Inst. 70, 343-352.
15. Maeura, Y., Weisburger, J. H., and Williams, G. M.(1984) Dose-dependent reduction of N-2-fluorentlacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylatedhydroxytoluene. Cancer Res. 44, 1604-1610.
16. Ito, N., Hirose, M., Fukushima, S., Tsuda, H., Shirai, T., and Tatamatsu, M.(1986) Studies on antioxidants:their carcinogenic and modifying effects on chemical carcinogenseis. Food Chem. Toxicol. 24,1071-1082.
17. Slag, T. T., and Bracken, W. M.(1977) The effects of antioxidants on skin tumor inhibition and aryl hydrocarbon hydroxylase. Cancer Res. 37, 1631-1635.
18. Tsuruta, Y., Subrahmanyam, V. V., Marshall, W., and O''Brien, P. J.(1985). Peroxidase-mediated irreversible binding of arylamine carcinogens to DNA in intact polymorphonuclear leukocytes activated by a tumor promoter. Chem-Biol, INTER. 53, 25-35.
19. Einisto P., Watanabe M., Ishidate M. and Nohmi T.(1991). Mutagenicity of 30 chemicals in S. typhmurium possessing different nitoreductase or O-acetyltransferase activities. Mutation Research 259, 95-112.
20. Walsh P.C.,Retik A.B.,Stamey T.A.,Vaughan,Jr.E.D. (1992) Compbell''s Urology,W.B.Saunders Co.
21. Kadlubar,F.F.,Talaska,G.,Lang,N.P.,et al(1988):Assessment of exporsure and susceptability to aromatic amines carcinogens.IARC Sci. Publ. P166.
22. 郭俊逸， 癌症的現代觀，八十五年初版，合記圖書出版社
23. Tannock,I.F.,Hill,R.P. (1992) The Basic Science of Oncology,McGraw-Hill Inc.
24. Aruoma,O.I.:Free radicals,oxidative stress,and antioxidants in human health and disease.J Am. Oil Chemists Soc 1998;75:199-212
25. Pryor WA:Cigarette smoke radicals and the role of free radicals in chemical carcinogenecity. Environmental Health Perspectives 1997;105(Suppl4):875-882.
26. Donnelly JK,Robinson DS:Free radicals in food.Free Rad Res 1955; 22: 147-176.
27. Kohlmeier L,et al: Tea and cancer prevention : An evaluation of the epidemiologic literature. Nutrition and Cancer 1997; 27: 1-13.
28. Tavani A, et al : Coffee and tea intake and risk of cancers of the colon and rectum: a study of 3, 530 cases and 7, 057 controls. int J Cancer 1997; 73 :193-197.
29. Kahl R, Kappus H :Toxicology of the synthetic antioxidants BHA and BHTin comparison with the natural antioxidant vitamin E: Z Lebensm Unters Forsch 1993 Apr: 196(4): 329-38.
30. Williams GM,Iatropoulos MJ:Inhibition of the hepatocarcinogenicity of aflatoxin B1 in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene:Cancer Lett 1996 Jun 24; 104(1):49-53.
31. Soni KB, Lahiri M, Chackradeo P, Bhide SV, Kuttan:Protective effect of food additives on aflatixin-induced mutagenicity and hepatocarcinogenicity:Cancer Lett 1997 May 19; 115(2):129.
32. Willians GM, Wang CX,Iatropoulos MJ:Toxicity studies of butylated hydroxyanisole and butylated hydroxytoluene. II.Chronic feeding studies:Food Chem Toxicol 1990 Dec; 28(12):799-806.